[1] |
Sichuan Provincial Clinical Center of Hydatid Disease; Special Committee of Hydatid Disease, Sichuan Medical Doctor Association. Expert consensus on diagnosis and treatment of alveolar hydatid disease (2020 edition)[J]. Chin J Bases Clin Gen Surg, 2020, 27(1): 13-17. DOI: 10.7507/1007-9424.201911105.
四川省包虫病临床医学研究中心, 四川省医师协会包虫病专业委员会. 泡型肝包虫病诊疗专家共识(2020版)[J]. 中国普外基础与临床杂志, 2020, 27(1): 13-17. DOI: 10.7507/1007-9424.201911105.
|
[2] |
BAUMANN S, SHI R, LIU W, et al. Worldwide literature on epidemiology of human alveolar echinococcosis: A systematic review of research published in the twenty-first century[J]. Infection, 2019, 47(5): 703-727. DOI: 10.1007/s15010-019-01325-2.
|
[3] |
LI YM, REN ZJ. Prowess in the diagnosis and treatment of he-patic echinococcosis[J]. Chin J Dig Surg, 2018, 17(12): 1141-1145. DOI: 10.3760/cma.j.issn.1673-9752.2018.12.001.
李玉民, 任志俭. 肝包虫病的诊断与治疗进展[J]. 中华消化外科杂志, 2018, 17(12): 1141-1145. DOI: 10.3760/cma.j.issn.1673-9752.2018.12.001.
|
[4] |
GOTTSTEIN B, LACHENMAYER A, BELDI G, et al. Diagnostic and follow-up performance of serological tests for different forms/courses of alveolar echinococcosis[J]. Food Waterborne Parasitol, 2019, 16: e00055. DOI: 10.1016/j.fawpar.2019.e00055.
|
[5] |
PEKTAŞB, ALTINTAŞN, AKPOLAT N, et al. Evaluation of the diagnostic value of the ELISA tests developed by using EgHF, Em2 and EmⅡ/3-10 antigens in the serological diagnosis of alveolar echinococcosis[J]. Mikrobiyol Bul, 2014, 48(3): 461-468. DOI: 10.5578/mb.7742.
|
[6] |
ZHAO CQ. Manifestations and diagnostic value of DWI in hepatic alveolar echinococcosis[J]. Chin J Med Imag Tech, 2017, 33(s1): 46-49. DOI: 10.13929/J.1003-3289.2017065.
赵闯绩. 肝泡型包虫病DWI病变特征及诊断价值[J]. 中国医学影像技术, 2017, 33(S1): 46-49. DOI: 10.13929/J.1003-3289.2017065.
|
[7] |
CAO JY, BAO HH, YANG XF, et al. Evaluation of the activity of microcysts in hepatic alveolar echinococcosis by magnetic resonance diffusion weighted imaging[J]. J Clin Radiol, 2018, 37(3): 428-431. DOI: 10.13437/j.cnki.jcr.2018.03.016.
曹佳媛, 鲍海华, 杨晓菲, 等. 磁共振扩散加权成像评价肝泡型包虫病微囊泡的活性[J]. 临床放射学杂志, 2018, 37(3): 428-431. DOI: 10.13437/j.cnki.jcr.2018.03.016.
|
[8] |
WEN YJ, SU Q, SU YG, et al. Comparative analysis of CT, MR and pathological features of intrahepatic cholangiocarcinoma[J]. J Imag Rese Medi Appl, 2019, 3(2): 77. DOI: 10.3969/j.issn.2096-3807.2019.02.051.
温亚军, 苏奇, 苏玉光, 等. 肝内胆管细胞癌CT、MR表现与病理特征对照分析[J]. 影像研究与医学应用, 2019, 3(2): 77. DOI: 10.3969/j.issn.2096-3807.2019.02.051.
|
[9] |
XIAO GQ, ZOU S. CT and MRI diagnosis of intrahepatic cholangiocarcinoma[J]. J FuJian Med, 2014, 36(3): 141-143. https://www.cnki.com.cn/Article/CJFDTOTAL-FJYY201403062.htm
肖桂卿, 邹松. 肝内胆管细胞癌CT和MRI影像诊断进展[J]. 福建医药杂志, 2014, 36(3): 141-143. https://www.cnki.com.cn/Article/CJFDTOTAL-FJYY201403062.htm
|